Michael H. Mulroy's Net Worth
$5.74 Million
Who is Michael H. Mulroy?
Michael H. Mulroy has an estimated net worth of $5.74 Million. This is based on reported shares across multiple companies, which include Lineage Cell Therapeutics, Inc., Asterias Biotherapeutics, Inc., AgeX Therapeutics, Inc., QUESTCOR PHARMACEUTICALS INC, and COMARCO INC.
SEC CIK
Michael H. Mulroy's CIK is 0001509725
Past Insider Trading and Trends
2018 was Michael H. Mulroy's most active year for acquiring shares with 11 total transactions. Michael H. Mulroy's most active month to acquire stocks was the month of June. 2014 was Michael H. Mulroy's most active year for disposing of shares, totalling 27 transactions. Michael H. Mulroy's most active month to dispose stocks was the month of July. 2014 saw Michael H. Mulroy paying a total of $712,000.00 for 86,000 shares, this is the most they've acquired in one year. In 2014 Michael H. Mulroy cashed out on 318,860 shares for a total of $6,214,108.83, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lineage Cell Therapeutics, Inc. (LCTX) Snapshot price: $1.06
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +2.78% | 7K |
$1.40 | $9,800.00 | 258.56K |
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +10.90% | 24.72K |
$2.20 | $54,384.00 | 251.56K |
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +596.84% | 194.27K |
—
|
—
| 226.82K |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Asterias Biotherapeutics, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +180.34% | 176.02K |
$0.95 | -$72,758.60 | 273.62K |
Mar 1
| |||
Form 4
| +3.33% | 3.14K |
$1.59 | $4,999.84 | 97.6K |
Scheduled
|
Aug 27
| ||
Form 4
| +3.22% | 2.95K |
$1.69 | $4,999.96 | 94.46K |
Scheduled
|
Jul 25
| ||
Form 4
| +3.47% | 3.07K |
$1.63 | $4,999.21 | 91.51K |
Scheduled
|
Jun 25
| ||
Form 4
| +3.70% | 3.15K |
$1.59 | $4,999.71 | 88.45K |
Scheduled
|
May 25
| ||
Form 4
| +4.60% | 3.75K |
$1.33 | $4,990.16 | 85.29K |
Scheduled
|
Apr 25
| ||
Form 4
| +3.61% | 2.84K |
$1.76 | $4,996.64 | 81.54K |
Scheduled
|
Mar 26
| ||
Form 4
| +545.73% | 66.51K |
$1.95 | -$55,298.10 | 78.7K |
Mar 15
| |||
Form 4
| +22.70% | 2.25K |
$2.22 | $4,999.79 | 12.19K |
Scheduled
|
Feb 26
| ||
Form 4
| +27.36% | 2.13K |
$2.34 | $4,999.96 | 9.93K |
Scheduled
|
Jan 25
| ||
Form 4
| +40.47% | 2.25K |
$2.22 | $4,988.34 | 7.8K |
Scheduled
|
Dec 26
| ||
Form 4
| +59.72% | 2.08K |
$2.41 | $5,003.16 | 5.55K |
Scheduled
|
Nov 27
| ||
Form 4
| +126.15% | 1.94K |
$2.55 | $4,944.45 | 3.48K |
Scheduled
|
Oct 25
| ||
Form 4
|
∞
| 1.54K |
$3.25 | $4,996.79 | 1.54K |
Scheduled
|
Sep 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AgeX Therapeutics, Inc. (AGE) Snapshot price: $0.3951
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
QUESTCOR PHARMACEUTICALS INC No price found
EVP, Strat. Affairs & GC
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -73.26K |
—
|
—
|
0
|
Aug 14
| |||
Form 4
| -14.73% | -11.35K |
$92.33 | -$923,347.50 | 65.71K |
Scheduled
|
Aug 6 - Aug 11
| ||
Form 4
| -1.69% | -1.30K |
$92.35 | -$120,424.40 | 75.76K |
Jul 31
| |||
Form 4
|
—
|
0
|
$52.57 | -$766,512.00 | 77.06K |
Jul 10
| |||
Form 4
|
—
|
0
|
$51.40 | -$743,344.50 | 77.06K |
Jun 10
| |||
Form 4
|
—
|
0
|
$51.11 | -$737,508.00 | 77.06K |
Apr 10 - May 12
| |||
Form 4
|
—
|
0
|
$49.64 | -$708,000.00 | 77.06K |
Apr 10
| |||
Form 4
|
—
|
0
|
$39.52 | -$505,590.51 | 77.06K |
Mar 10
| |||
Form 4
| +17.15% | 11.28K |
$79.46 | -$997,381.92 | 77.06K |
Feb 24
| |||
Form 4
| +17.93% | 10K |
—
|
—
| 65.78K |
Jul 31
| |||
Form 4/A
| +1,754.31% | 52.14K |
—
|
—
| 55.11K |
Feb 24
| |||
Form 4
| +2,463.06% | 52.14K |
—
|
—
| 54.26K |
Feb 24
| |||
Form 4
| +89.53% | 1K |
$40.00 | $40,000.00 | 2.12K |
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COMARCO INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +133.33% | 40K |
—
|
—
| 70K |
Oct 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||